Autonomix Medical
Excelsior
About Autonomix Medical
Autonomix Medical is a developer of a novel technology designed to bring clarity to minimally invasive renal denervation to treat heart disease. Its technology is used to develop minimally invasive neural monitoring and treatment devices for next-generation neuromodulation therapies that enable medical practitioners to accurately assess and treat peripheral and neural mediated disease. The company develops a proprietary microchip, hardware, and software which can be integrated into a catheter or other device to dramatically improve electrophysiologic signal fidelity and simplify data analysis. It was founded in 2014 and is headquartered in Excelsior, Minnesota.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $26.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2025)
- Ticker: nasdaq:AMIX
- Website: autonomix.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/autonomix-medical-86029 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.